Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis

Oral Diseases

Volumn 12, Issue 2, 2006, Pages 187-193

  Evio S ^a,b   Tarkkila, L ^b   Sorsa, T ^a,b   Furuholm, J ^b   Valimaki M J ^a   Ylikorkala, O ^a   Tiitinen, A ^a   Meurman, J H ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Alendronate; Dental health; Hormone replacement therapy; Matrix metalloproteinase; Osteoporosis; Periodontitis

Indexed keywords

ALENDRONIC ACID; CALCIUM; ESTRADIOL PLUS NORETHISTERONE ACETATE; NEUTROPHIL COLLAGENASE; VITAMIN D;

AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BURNING MOUTH SYNDROME; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL HEALTH; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEMUR NECK; GINGIVITIS; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; SALIVATION; SCORING SYSTEM; TOOTH DISEASE; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; HUMANS; LONGITUDINAL STUDIES; MATRIX METALLOPROTEINASE 8; NORETHINDRONE; OSTEOPOROSIS, POSTMENOPAUSAL; PERIODONTIUM; PLACEBOS; SALIVA; SECRETORY RATE;

EID: 33645128803     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01186.x     Document Type: Article

References (57)

1. Ainamo J Barmes D Beagrie G et al 1982 Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN) Int Dent J 32 281 291
2. Birkedal-Hansen H 1993 Role of matrix metalloproteinases in human periodontal diseases J Periodontal 64 474 484
3. Bone HG Greenspan SL McKeever C et al for the Alendronate/Estrogen Study Group 2000 Alendronate and estrogen effects in postmenopausal women with low bone mineral density J Clin Endocrinol Metab 85 720 726
4. Chen HY Cox SW Eley BM et al 2000 Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients J Clin Periodontol 27 366 369
5. Civitelli R Pilgram TK Dotson M et al 2002 Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy Arch Intern Med 162 2634 2635
6. Consensus Development Conference 1993 Diagnosis and treatment of osteoporosis Am J Med 94 646 650
7. El-Shinnawi UM El-Tantawy SI 2003 The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial) J Int Acad Periodontol 5 5 10
8. Eliasson L Carlen A Laine M et al 2003 Minor gland and whole saliva in postmenopausal women using a low potency oestrogen (oestriol) Arch Oral Biol 48 511 517
9. Eviö S Tiitinen A Laitinen K et al 2004 Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis J Clin Endocrinol Metab 89 626 631
10. Friedlander AH 2002 The physiology, medical management and oral implications in menopause J Am Dent Assoc 133 73 81
11. Golub LM Sorsa T Lee HM et al 1995 Doxicycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingival J Clin Periodontol 22 100 109
12. Golub LM Lee HM Greenwald RA et al 1997 A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis Inflam Res 46 310 319
13. Grodstein F Colditz GA Stampfer MJ 1998 Tooth loss and hormone use in postmenopausal women Compend Contin Educ Dent Suppl 22S 9 16
14. Grossi SG 1998 Effect of estrogen supplementation on periodontal disease Compend Contin Educ Dent Suppl 22 S30 S36
15. Hakeberg M Beggren U Hägglin C et al 1997 Reported burning mouth syndrome among middle-aged and elderly women Eur J Oral Sci 105 539 543
16. Hanemaaijer R Sorsa T Konttinen YT et al 1997 Matrix metalloproteinase-8 expression by rheumatoid synovial fibroblasts and endothelial cells. Regulation by doxycycline and tumor necrosis factor α J Biol Chem 272 31504 31509
17. Heikkilä P Teronen O Moilanen M et al 2002 Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20) but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines Anti-Cancer Drugs 13 245 254
18. Hildebolt CF Pilgram TK Dotson M et al 2004 Estrogen and/or calcium plus vitamin D increase mandibular bone mass J Preriodontol 75 811 816
19. Ingman T Sorsa T Michaelis J et al 1994 Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromeolysin-1 in adult periodontitis Scand J Dent Res 102 342 349
20. Ingman T Tervahartiala T Ding Y et al 1996 Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients J Clin Periodontol 23 1127 1132
21. Jeffcoat MK 1998 Osteoporosis: a possible modifying factor in oral bone loss Ann Periodontol 3 312 321
22. Krall EA Dawson-Hughes B Hannan MT et al 1998 Postmenopausal estrogen replacement and tooth retention Compend Contin Educ Dent Suppl 22 S17 S22
23. Krall EA Wehler C Garcia RI et al 2001 Calcium and vitamin D supplements reduce tooth loss in the elderly Am J Med 111 452 456
24. Laine M Leimola-Virtanen R 1996 Effect of hormone replacement therapy on salivary flow rate effect and pH on perimenopausal and postmenopausal women Arch Oral Biol 41 91 96
25. Laine P Meurman JH Tenovuo J et al 1992 Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs Oral Oncol Eur J Cancer 28B 125 128
26. Lauhio A Salo T Ding Y et al 1994 In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis Clin Exp Immunol 98 21 28
27. Leimola-Virtanen R Helenius H Laine M 1997 Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women Maturitas 27 145 151
28. Leimola-Virtanen R Salo T Toikkanen S et al 2000 Expression of estrogen (ER) in mucosa and salivary glands Maturitas 36 131 137
29. Liao EY Luo XH 2001 Effects of 17beta-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor metalloprotein 1 in human osteoblast-like cultures Endocrine 15 291 295
30. Liede K Haukka J Hietanen J et al 1999 The effect of smoking cessation on salivary proteinase and matrix metalloproteinase levels J Periodontol 70 1361 1368
31. Lindsay R Cosman F Lobo RA et al 1999 Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial J Clin Endocrinol Metab 84 3076 3081
32. Mäntylä P Stenman M Kinane DF et al 2003 Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis J Periodontal Res 38 436 439
33. Meurman JH Rantonen P 1994 Salivary flow rate, buffering capacity and yeasr counts in 187 consecutive adult patients from Kuopio, Finland Scand J Dent Res 102 227 234
34. Meurman JH Collin H-L Niskanen L et al 1998 Saliva in non-insulin-dependent diabetic patients and controls - role of autonomic nervous system Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 69 76
35. Närhi TO 1994 Prevalence of subjective feelings of dry mouth in the elderly J Dent Res 73 20 25
36. Närhi TO Ainamo A Meurman JH 1993 Salivary yeasts, saliva, and oral mucosa in the elderly J Dent Res 2 1009 1014
37. Nomura T Ishii A Oishi Y et al 1998 Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases Oral Dis 4 231 240
38. Owen CA Hu Z Lopez-Otin C et al 2004 Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase J Immunol 172 7791 7803
39. Paganini-Hill A 1995 The benefits of estrogen replacement therapy on oral health. Leisure World cohort Arch Intern Med 155 2325 2329
40. Pajukoski H Meurman JH Snellman-Gröhn S et al 1997 Salivary flow and composition in home-living elderly patients referred to an acute care geriatric ward Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 265 271
41. Pajukoski H Meurman JH Halonen P et al 2001 Prevalence of dry mouth and burning mouth inacutely hospitalized elderly patients and outpatients in relation to saliva, medication and systemic diseases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 641 649
42. Parikka V Lehenkari P Sassi M-L et al 2001 Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts Endocrinol 142 5371 5378
43. Payne JB Reinhardt RA Nummikoski PV et al 1999 Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women Osteoporos Int 10 34 40
44. Pirilä E Ranamurthy N Maisi P et al 2001 Wound healing in ovariectomiced rats. Effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases-8 and -13 and type I collagen expression Curr Med Chem 8 281 294
45. Reinhardt RA Payne JB Maze CA et al 1999 Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women J Periodontol 70 823 828
46. Ronderos M Jacobs DR Himes JH et al 2000 Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of US adults from NHANES III J Clin Periodontol 27 778 786
47. Salo T Mäkelä M Kylmäniemi M et al 1994 Expression of matrix metalloproteinase-2 and -9 during early human wound healing Lab Invest 70 176 182
48. Sorsa T Uitto VJ Suomalainen K et al 1998 Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes J Periodontal Res 23 386 393
49. Sorsa T Mäntylä P Rönkä H et al 1999 Scientific basis of matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease monitoring Ann NY Acad Sci 878 130 140
50. Sorsa T Tjäderhane L Salo T 2004 Matrix metalloproteinase in oral diseases Oral Diseases 10 311 318
51. Tarkkila L Linna M Tiitinen A et al 2001 Oral symptoms at menopause - the role of hormone replacement therapy Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 276 280
52. Teronen O Heikkilä P Konttinen YT et al 1999 MMP inhibition and downregulation by bisphosphonates Ann N Y Acad Sci 878 453 465
53. Tezal M Wactawski-Wende J Grossi SG et al 2000 The relationship between bone mineral density and periodontitis in postmenopausal women J Periodontol 71 1492 1498
54. Tiras MB Noyan V Yildiz A et al 2000 Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study Hum Reprod 15 2087 2092
55. Wactawski-Wende J Grossi SG Trevisan M et al 1996 The role of osteopenia in oral bone loss and periodontal disease J Periodontol 67 1076 1084
56. Wardrop RW Hailes J Burger H et al 1989 Oral discomfort at menopause Oral Surg Oral Med Oral Pathol 67 535 540
57. World Health Organization 1987 Oral health surveys. Basic methods 3rd edn WHO Geneva